SCHEMBL15426894

SCHEMBL15426894

COC(=O)C(CSC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCCN)NC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC15A2 Q16348 1/20 0.46
▸ SLC6A5 Q9Y345 1/20 0.45
▸ CCR2 P41597 2/20 0.42
▸ CPB2 Q96IY4 1/20 0.40
▸ EPHX2 P34913 1/20 0.40
▸ REN P00797 2/20 0.39
▸ HTR1D P28221 2/20 0.38
▸ HTR2C P28335 2/20 0.38
▸ HTR1E P28566 2/20 0.38
▸ HTR2B P41595 2/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR3A P46098 1/20 0.38
▸ FAAH O00519 1/20 0.37
▸ CNR1 P21554 1/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ PDE5A O76074 1/20 0.37
▸ SCN9A Q15858 1/20 0.37
▸ ACE2 Q9BYF1 1/20 0.37
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16819849 1.00 SLC15A2 (0.46) SLC15A2SLC6A5CCR2CPB2EPHX2
SCHEMBL16819880 0.95 SLC15A2 (0.44) SLC15A2SLC6A5CCR2CPB2REN
SCHEMBL16819881 0.95 SLC15A2 (0.44) SLC15A2SLC6A5CCR2CPB2REN
SCHEMBL15426879 0.95 SLC15A2 (0.44) SLC15A2SLC6A5CCR2CPB2REN
Hydrochloric Acid SCHEMBL16819886 0.94 SLC15A2 (0.43) SLC15A2SLC6A5CCR2CPB2REN
Hydrochloric Acid SCHEMBL16819887 0.94 SLC15A2 (0.43) SLC15A2SLC6A5CCR2CPB2REN
Hydrochloric Acid SCHEMBL16819884 0.94 SLC15A2 (0.43) SLC15A2SLC6A5CCR2CPB2REN
SCHEMBL16819866 0.90 SLC15A2 (0.47) SLC15A2SLC6A5CPB2EPHX2REN
SCHEMBL15426857 0.90 SLC15A2 (0.54) SLC15A2SLC6A5CPB2EPHX2REN
SCHEMBL16819885 0.90 SLC15A2 (0.54) SLC15A2SLC6A5CPB2EPHX2REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10028935-B2 Stabilized multi-functional antioxidant compounds and methods of use XPD HOLDINGS, LLC (US) 2018-07-24 — — US claimed
US-20170135986-A1 STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE XPD HOLDINGS, LLC 2017-05-18 — — US claimed
US-9382211-B2 Stabilized multi-functional antioxidant compounds and methods of use XPD HOLDINGS, LLC (US) 2016-07-05 — — US claimed
US-20150175552-A1 STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE XPD HOLDINGS, LLC 2015-06-25 — — US claimed
US-10028935-B2 Stabilized multi-functional antioxidant compounds and methods of use XPD HOLDINGS, LLC (US) 2018-07-24 — — US disclosed
US-10028935-B2 Stabilized multi-functional antioxidant compounds and methods of use XPD HOLDINGS, LLC (US) 2018-07-24 — — US disclosed
US-20170135986-A1 STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE XPD HOLDINGS, LLC 2017-05-18 — — US disclosed
US-20170135986-A1 STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE XPD HOLDINGS, LLC 2017-05-18 — — US disclosed
US-9593079-B2 Stabilized multi-functional antioxidant compounds and methods of use XPD HOLDINGS, LLC (US) 2017-03-14 — — US disclosed
US-9382211-B2 Stabilized multi-functional antioxidant compounds and methods of use XPD HOLDINGS, LLC (US) 2016-07-05 — — US disclosed
US-9382211-B2 Stabilized multi-functional antioxidant compounds and methods of use XPD HOLDINGS, LLC (US) 2016-07-05 — — US disclosed
US-20160185718-A1 Stabilized Multi-Functional Antioxidant Compounds and Methods of Use XPD HOLDINGS, LLC 2016-06-30 — — US disclosed
US-20150175552-A1 STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE XPD HOLDINGS, LLC 2015-06-25 — — US disclosed
US-20150175552-A1 STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE XPD HOLDINGS, LLC 2015-06-25 — — US disclosed
WO-2014011624-A2 STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE XPD HOLDINGS LLC (US) 2014-01-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10028935-B2 Stabilized multi-functional antioxidant compounds and methods of use SOD1, GPX4, SOD3 SLC15A2 2163/4885SLC6A5 3930/4885CCR2 4269/4885
US-20150175552-A1 STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE SOD1, GPX4, SOD3 SLC15A2 2163/4885SLC6A5 3930/4885CCR2 4269/4885
US-20170135986-A1 STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE SOD1, GPX4, SOD3 SLC15A2 2163/4885SLC6A5 3930/4885CCR2 4269/4885
US-20160185718-A1 Stabilized Multi-Functional Antioxidant Compounds and Methods of Use SOD1, GPX4, SOD3 SLC15A2 2163/4885SLC6A5 3930/4885CCR2 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback